Kurtul, Bengi Ececakmak, Ayse IdilElbeyli, AhmetOezarslan oezcan, DenizOezcan, Sait CoskunCankurtaran, Veysel2024-09-182024-09-1820202515-8414https://doi.org/10.1177/2515841420971949https://hdl.handle.net/20.500.12483/10748Purpose: To investigate platelet-to-lymphocyte ratio (PLR) in retinal vein occlusion (RVO) patients. Methods: In this study, we retrospectively reviewed data of 32 patients with RVO (RVO group) and 32 age- and sex-matched participants without RVO (control group) between January 2017 and March 2019. The PLR was determined by dividing the platelet count by the lymphocyte count. Results: Age and gender were comparable between the groups (p = 0.204 and p = 0.800, respectively). PLR was significantly elevated in the RVO group compared with the control group (137 (113-164) vs 101 (86-129), p = 0.001)). In the receiver operator characteristics curve analysis, the optimal cut-off value of PLR for predicting RVO was 123, with 69% sensitivity and 72% specificity. Conclusion: We report that PLR are elevated in RVO, suggesting that PLR may be a useful marker for RVO.eninfo:eu-repo/semantics/openAccessinflammationplatelet-to-lymphocyte ratioretinal vein occlusionthrombusArticle1210.1177/2515841420971949332831552-s2.0-85109001486Q1WOS:000593493800001N/A